Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Clinical trial NCT04731844 · COMPLETED

Trial details

NCT number: NCT04731844
Sponsor: University of Rochester
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Multiple Myeloma Smoldering Multiple Myeloma (SMM)Monoclonal Gammopathy of Undetermined Significance

Start date: 2021-12-14
Primary completion: 2024-09-19
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.